This was corroborated by our findings that pharmacological inhibition of glycolysis and the PPP reduced proliferation in gastric cancer cells, whereas overexpression of PFKFB3 and G6PD augmented proliferation in these cells. The gene discussed is G6PD; the disease is gastric cancer.